Utility of HE4 and CA-125 as predictive and prognostic factors in preoperative assessment of endometrial cancer

被引:0
|
作者
Gao, M. [1 ]
Zhang, N. [1 ]
Gao, Y. [1 ]
机构
[1] Beijing Canc Hosp, Beijing, Peoples R China
关键词
D O I
10.1016/j.ygyno.2018.04.375
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
365
引用
收藏
页码:164 / 164
页数:1
相关论文
共 50 条
  • [41] Utility of Serum HE4 in Diagnosis and Prognosis of Endometrial Cancer
    O'Toole, S. A.
    Rizmee, S.
    Norris, L.
    Cullen, M.
    Zainulabdin, A.
    Long, J. C.
    Martin, F.
    Cooney, A.
    Ripollone, S.
    Ibrahim, N.
    Abu Saadeh, F.
    Kamran, W.
    Murphy, C.
    D'Arcy, T.
    Gleeson, N. C.
    O'Leary, J. J.
    JOURNAL OF PATHOLOGY, 2015, 237 : S15 - S15
  • [42] Prognostic and predictive value of combined HE-4 and CA-125 biomarkers during chemotherapy in patients with epithelial ovarian cancer
    Potenza, Enrico
    Parpinel, Giulia
    Laudani, Maria E.
    Macchi, Chiara
    Fuso, Luca
    Zola, Paolo
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2020, 35 (04): : 20 - 27
  • [43] Prognostic and predictive relevance of CA-125 at primary surgery of ovarian cancer
    Dina Mury
    Linn Woelber
    Sabine Jung
    Christine Eulenburg
    Matthias Choschzick
    Isabell Witzel
    Joerg Schwarz
    Fritz Jaenicke
    Sven Mahner
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1131 - 1137
  • [44] Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4
    Capriglione, Stella
    Plotti, Francesco
    Miranda, Andrea
    Lopez, Salvatore
    Scaletta, Giuseppe
    Moncelli, Michele
    Luvero, Daniela
    Nardone, Carlo De Cicco
    Terranova, Corrado
    Montera, Roberto
    Angioli, Roberto
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (01) : 9 - 18
  • [45] Prognostic and predictive relevance of CA-125 at primary surgery of ovarian cancer
    Mury, Dina
    Woelber, Linn
    Jung, Sabine
    Eulenburg, Christine
    Choschzick, Matthias
    Witzel, Isabell
    Schwarz, Joerg
    Jaenicke, Fritz
    Mahner, Sven
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (07) : 1131 - 1137
  • [46] PROGNOSTIC VALUE OF SERUM HE4 LEVEL IN ENDOMETRIAL CANCER
    Rajadevan, N.
    McNally, O.
    Neesham, D.
    Richards, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 1169 - 1169
  • [47] HE4 is an independent prognostic marker in endometrial cancer patients
    Mutz-Dehbalaie, Irene
    Egle, Daniel
    Fessler, Siegfried
    Hubalek, Michael
    Fiegl, Heidi
    Marth, Christian
    Widschwendter, Andreas
    GYNECOLOGIC ONCOLOGY, 2012, 126 (02) : 186 - 191
  • [48] HE4 HAS A ROLE IN IDENTIFYING HIGH RISK PROGNOSTIC FACTORS IN ENDOMETRIAL CANCER
    O'Toole, S.
    Foley, M.
    Rizmee, S.
    Norris, L.
    Kamran, W.
    Ibrahim, N.
    Ward, M.
    Thompson, C.
    Murphy, C.
    Anglim, M.
    D'Arcy, T.
    Farah, N.
    O'Connor, H.
    O'Leary, J.
    AbuSaadeh, F.
    Gleeson, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A351 - A352
  • [49] HE4 AND CA125 IN OVARIAN CANCER PATIENTS
    Kotowicz, B.
    Fuksiewicz, M.
    Kowalska, M.
    Sobiczewski, P.
    Skrzypczak, M.
    Spiewankiewicz, B.
    Kaminska, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [50] Value of HE4 combined with cancer Antigen 125 in the diagnosis of Endometrial Cancer
    Dong, Chunhua
    Liu, Ping
    Li, Chao
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2017, 33 (04) : 1013 - 1017